cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA248854 | .a | 5724 to 6032 | 10 to 320 | 311/323 (96 %) | 19 diff (94.2 %id) | ||||
AA331427 | Embryo, 8 weeks | .a | 6247 to 6569 | 1 to 326 | 326/332 (98 %) | 5 diff (98.5 %id) | |||
AA332782 | Embryo, 8 weeks | .a | 6247 to 6489 | 1 to 243 | 243/253 (96 %) | 1 diff (99.7 %id) | |||
AA332988 | Embryo, 8 weeks | .a | 6247 to 6489 | 1 to 243 | 243/243 (100 %) | 1 diff (99.6 %id) | |||
AA333011 | Embryo, 8 weeks | .a | 6247 to 6620 | 1 to 376 | 376/382 (98 %) | 7 diff (98.2 %id) | |||
AA385767 | thyroid gland | .a | 6411 to 6709 | 1 to 299 | 299/299 (100 %) | 0 diff (100 %id) | |||
AB010894 | brain | .c | 261 to 5051 | 1 to 4791 | S124F | tiling clone, | 4791/4791 (100 %) | 2 diff (100.0 %id) | |
BP198883 | brain | .e | 675 to 1262 | 1 to 592 | tiling clone, | 592/592 (100 %) | 9 diff (98.5 %id) | ||
AF401654 | .b | 503 to 5064 | 1 to 4562 | S124F | tiling clone, | 4562/4562 (100 %) | 1 diff (100.0 %id) | ||
AF401656 | .a | 503 to 4891 | 1 to 4389 | S124F | tiling clone, | 4389/4389 (100 %) | 2 diff (100.0 %id) | ||
AK023358 | ovary, tumor tissue | .a | 4538 to 6374 | 1 to 1837 | available from FLJ, | 1837/1837 (100 %) | 5 diff (99.8 %id) | ||
AK124433 | bladder | .q-u | 1 to 2180 | 6 to 2185 | exact | tiling clone, available from FLJ, | 2185/2185 (100 %) | 1 diff (100.0 %id) | |
AK127518 | thalamus | .i-u | 1 to 3329 | 1 to 3329 | S161P | tiling clone, available from FLJ, | 3329/3329 (100 %) | 2 diff (100.0 %id) | |
AK130632 | Spleen | .q-u | 473 to 2180 | 1 to 1708 | exact | available from FLJ, | 1708/1708 (100 %) | 1 diff (100.0 %id) | |
AK289803 | brain | .c | 408 to 4587 | 1 to 4180 | D428H I1001T | tiling clone, | 4180/4180 (100 %) | 2 diff (100.0 %id) | |
AK307794 | amygdala | .d | 1 to 972 | 1 to 971 | tiling clone, | 971/971 (100 %) | 1 diff (99.9 %id) | ||
AL050184 | uterus | .a | 6852 to 7738 | 1 to 887 | available from DKFZ, AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 887/887 (100 %) | 0 diff (100 %id) | |
AW377011 | colon | .a | 2384 to 2652 | 270 to 1 | 270/270 (100 %) | 2 diff (99.3 %id) | |||
AW497636 | .c | 5968 to 6064 | 95 to 1 | 95/95 (100 %) | 2 diff (97.9 %id) | ||||
AW609128 | stomach | .a | 3054 to 3257 | 212 to 6 | 207/212 (97 %) | 1 diff (99.6 %id) | |||
AW846037 | colon | .e | 1 to 165 | 1 to 165 | 165/165 (100 %) | 2 diff (98.8 %id) | |||
AW846052 | colon | .e | 1 to 165 | 1 to 165 | tiling clone, | 165/165 (100 %) | 2 diff (98.8 %id) | ||
AW952520 | .a | 6248 to 6721 | 1 to 474 | 474/485 (97 %) | 17 diff (96.5 %id) | ||||
BE000126 | breast_normal | .a | 1211 to 1530 | 11 to 333 | 320/333 (96 %) | 6 diff (98.2 %id) | |||
BE077090 | breast | .a | 5448 to 5763 | 15 to 330 | 316/330 (95 %) | 6 diff (98.2 %id) | |||
BE178089 | head_neck | .a | 6296 to 6911 | 643 to 26 | Submitted on the opposite strand | 618/643 (96 %) | 0 diff (100 %id) | ||
BE178357 | head_neck | .a | 6242 to 6489 | 8 to 258 | 251/272 (92 %) | 22 diff (92.0 %id) | |||
BE818804 | breast_normal | .a | 5783 to 6056 | 280 to 6 | 275/285 (96 %) | 0 diff (100 %id) | |||
BE818816 | breast_normal | .a | 5783 to 6076 | 295 to 1 | 295/300 (98 %) | 2 diff (99.4 %id) | |||
BE833257 | ovary | .a | 5820 to 6195 | 377 to 4 | 374/377 (99 %) | 0 diff (100 %id) | |||
BE835921 | prostate_normal | .a | 1207 to 1519 | 312 to 1 | 312/323 (96 %) | 3 diff (99.1 %id) | |||
BE840899 | stomach_normal | .a | 2546 to 2765 | 1 to 221 | 221/224 (98 %) | 4 diff (98.3 %id) | |||
BE925619 | amnion_normal | .a | 3047 to 3223 | 178 to 2 | 177/178 (99 %) | 2 diff (98.9 %id) | |||
BF090013 | nervous_normal | .a | 1183 to 1323 | 4 to 145 | 142/145 (97 %) | 6 diff (95.9 %id) | |||
BF329113 | breast_normal | .a | 4778 to 5006 | 1 to 229 | 229/239 (95 %) | 6 diff (97.5 %id) | |||
BF736720 | bladder_tumor | .a | 7133 to 7610 | 478 to 1 | Submitted on the opposite strand | 478/478 (100 %) | 6 diff (98.8 %id) | ||
BF821548 | kidney_tumor | .a | 5789 to 6084 | 298 to 4 | Submitted on the opposite strand | 295/298 (98 %) | 0 diff (100 %id) | ||
BF821632 | kidney_tumor | .a | 5789 to 6079 | 287 to 1 | Submitted on the opposite strand | 287/287 (100 %) | 3 diff (99.0 %id) | ||
BF960082 | nervous_normal | .a | 1178 to 1617 | 446 to 7 | 440/446 (98 %) | 1 diff (99.8 %id) | |||
BF963945 | nervous_normal | .a | 1097 to 1356 | 311 to 50 | 262/311 (84 %) | 0 diff (100 %id) | |||
BF964138 | nervous_normal | .a | 1097 to 1617 | 15 to 535 | 521/540 (96 %) | 7 diff (98.8 %id) | |||
BI033821 | nervous_normal | .a | 1097 to 1610 | 20 to 532 | 513/532 (96 %) | 8 diff (98.5 %id) | |||
BI033822 | nervous_normal | .a | 1097 to 1577 | 18 to 498 | 481/498 (96 %) | 7 diff (98.6 %id) | |||
BI035280 | nervous_normal | .a | 1097 to 1610 | 515 to 2 | 514/526 (97 %) | 4 diff (99.3 %id) | |||
BI055044 | placenta_normal | .a | 7271 to 7459 | 7 to 196 | 190/199 (95 %) | 3 diff (98.5 %id) | |||
DA045848 | bladder | .q-u | 1 to 454 | 6 to 459 | capped | 458/458 (100 %) | 0 diff (100 %id) | ||
DB296155 | bladder | .q-u | 1647 to 2180 | 534 to 1 | 534/534 (100 %) | 0 diff (100 %id) | |||
BM505653 | insulinoma, Pancreas | .d | 827 to 1405 | 579 to 1 | tiling clone, | 579/582 (99 %) | 13 diff (97.8 %id) | ||
BM509021 | insulinoma, Pancreas | .a | 3260 to 3411 | 1 to 152 | 152/152 (100 %) | 5 diff (96.8 %id) | |||
BQ338965 | nervous_normal | .a | 1157 to 1542 | 481 to 95 | 387/481 (80 %) | 0 diff (100 %id) | |||
BQ340395 | nervous_normal | .a | 1097 to 1611 | 1 to 515 | 515/515 (100 %) | 6 diff (98.9 %id) | |||
BQ340416 | nervous_normal | .a | 1097 to 1612 | 1 to 516 | 516/518 (99 %) | 14 diff (97.3 %id) | |||
BQ340507 | nervous_normal | .a | 1115 to 1611 | 496 to 1 | 496/496 (100 %) | 10 diff (98.0 %id) | |||
DA099551 | cerebellum | .a | 1880 to 2442 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DA110185 | cerebellum | .a | 1 to 498 | 2 to 500 | tiling clone, capped | 499/499 (100 %) | 1 diff (99.8 %id) | ||
DC317730 | amygdala | .d | 1 to 573 | 1 to 572 | 572/572 (100 %) | 1 diff (99.9 %id) | |||
DA234500 | brain | .a | 409 to 981 | 2 to 574 | tiling clone, capped | 573/573 (100 %) | 0 diff (100 %id) | ||
DA240142 | brain | .b | 2845 to 3427 | 2 to 584 | capped | 583/583 (100 %) | 0 diff (100 %id) | ||
DA242396 | brain | .j | 28 to 612 | 2 to 586 | capped | 585/585 (100 %) | 1 diff (99.9 %id) | ||
DA312768 | hippocampus | .j | 1 to 541 | 2 to 542 | capped | 541/541 (100 %) | 0 diff (100 %id) | ||
DC333089 | hippocampus | .d | 62 to 617 | 1 to 556 | tiling clone, | 556/556 (100 %) | 0 diff (100 %id) | ||
DA336098 | hippocampus | .j | 1 to 575 | 2 to 576 | tiling clone, capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DA369173 | subthalamic nucleus | .c | 4443 to 5001 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
DA390644 | thalamus | .b | 2522 to 3094 | 2 to 575 | capped | 574/574 (100 %) | 1 diff (99.9 %id) | ||
DC341727 | thalamus | .d | 14 to 605 | 1 to 592 | 592/592 (100 %) | 1 diff (99.9 %id) | |||
DA410241 | thalamus | .a | 4044 to 4596 | 2 to 554 | capped | 553/554 (99 %) | 1 diff (99.9 %id) | ||
DA415713 | thalamus | .i-u | 1 to 559 | 2 to 561 | capped | 560/560 (100 %) | 1 diff (99.9 %id) | ||
BX089296 | placenta | .a | 7111 to 7738 | 1 to 629 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 629/629 (100 %) | 1 diff (99.9 %id) | |
BX280450 | heart | .p | 1 to 435 | 1 to 435 | tiling clone, | 435/437 (99 %) | 2 diff (99.6 %id) | ||
BX282162 | pooled | .a | 4852 to 5108 | 1 to 257 | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 257/257 (100 %) | 0 diff (100 %id) | |
CN292151 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 6244 to 6798 | 1 to 555 | 555/555 (100 %) | 0 diff (100 %id) | |||
CN372418 | embryonic stem cells, DMSO-treated H9 cellline | .a | 5830 to 6446 | 1 to 617 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 617/617 (100 %) | 1 diff (99.9 %id) | |
CN372419 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 5488 to 6067 | 1 to 578 | 578/578 (100 %) | 4 diff (99.4 %id) | |||
CN372420 | embryonic stem cells, DMSO-treated H9 cellline | .a | 4816 to 5257 | 1 to 442 | 442/442 (100 %) | 4 diff (99.1 %id) | |||
CN428096 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .d | 707 to 1078 | 1 to 372 | 372/372 (100 %) | 0 diff (100 %id) | |||
CN428097 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 1847 to 2382 | 1 to 536 | 536/536 (100 %) | 1 diff (99.9 %id) | |||
CN428098 | embryonic stem cells, cell lines H1, H7, andH9 | .h | 1 to 661 | 1 to 660 | tiling clone, | 660/661 (99 %) | 2 diff (99.7 %id) | ||
CN428099 | embryonic stem cells, DMSO-treated H9 cellline | .a | 146 to 742 | 1 to 597 | 597/597 (100 %) | 4 diff (99.4 %id) | |||
CN428100 | embryonic stem cells, DMSO-treated H9 cellline | .j | 489 to 1002 | 1 to 514 | tiling clone, | 514/514 (100 %) | 1 diff (99.9 %id) | ||
CN428101 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 1372 to 1958 | 1 to 587 | 587/587 (100 %) | 0 diff (100 %id) | |||
CR738848 | pooled germ cell tumors | .a | 7402 to 7744 | 1 to 343 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 343/343 (100 %) | 0 diff (100 %id) | |
CR741647 | carcinoid, lung | .a | 6184 to 6675 | 1 to 493 | 493/493 (100 %) | 1 diff (99.8 %id) | |||
CR746237 | .f | 1276 to 1750 | 1 to 476 | 476/476 (100 %) | 1 diff (99.8 %id) | ||||
CA393929 | eye, RPE/choroid | .n | 1 to 530 | 1 to 530 | exact | tiling clone, | 530/530 (100 %) | 0 diff (100 %id) | |
AL044443. matches multiple genes | testis | .a | 4835 to 5108 | 288 to 15 | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base), also hits gene GIT1 | 274/274 (100 %) | 0 diff (100 %id) | |
BX509702 | .a | 4943 to 5109 | 1 to 167 | 167/293 (56 %) | 1 diff (99.7 %id) | ||||
BX506903 | Liver | .a | 5876 to 6316 | 1 to 446 | 446/446 (100 %) | 8 diff (98.3 %id) | |||
BP226418 | .s-u | 426 to 981 | 1 to 558 | F74S V79L V81L F82S S83F ... | tiling clone, | 558/558 (100 %) | 2 diff (99.7 %id) | ||
DT219440 | brain | .a | 6496 to 7187 | 1 to 692 | 692/692 (100 %) | 1 diff (99.9 %id) | |||
DT220503 | brain | .a | 7301 to 7744 | 1 to 443 | 443/450 (98 %) | 3 diff (99.4 %id) | |||
DA505175 | brain | .a | 5127 to 5705 | 2 to 578 | capped | 577/577 (100 %) | 4 diff (99.4 %id) | ||
DA530667 | brain | .a | 2269 to 2885 | 2 to 618 | capped | 617/617 (100 %) | 1 diff (99.9 %id) | ||
DA535701 | heart | .a | 4790 to 5370 | 20 to 600 | capped | 581/599 (96 %) | 6 diff (99.0 %id) | ||
FN046352 | breast carcinoma | .a | 6177 to 6229 | 53 to 1 | Submitted on the opposite strand | 53/53 (100 %) | 0 diff (100 %id) | ||
FN050730 | breast carcinoma | .a | 5530 to 5607 | 78 to 1 | Submitted on the opposite strand | 78/78 (100 %) | 0 diff (100 %id) | ||
FN067655 | breast carcinoma | .a | 6144 to 6215 | 1 to 70 | 70/71 (98 %) | 3 diff (95.8 %id) | |||
FN085437 | breast carcinoma | .a | 5453 to 5551 | 1 to 96 | 96/104 (92 %) | 7 diff (93.3 %id) | |||
FN103349 | breast carcinoma | .a | 5659 to 5737 | 78 to 1 | Submitted on the opposite strand | 78/94 (82 %) | 1 diff (99.0 %id) | ||
FN137942 | breast carcinoma | .r-u | 573 to 651 | 78 to 3 | Submitted on the opposite strand | 76/87 (87 %) | 0 diff (100 %id) | ||
FN148681 | breast carcinoma | .a | 7290 to 7397 | 1 to 102 | 102/102 (100 %) | 6 diff (94.2 %id) | |||
FN149622 | breast carcinoma | .f | 1701 to 1803 | 104 to 1 | Submitted on the opposite strand | 104/104 (100 %) | 2 diff (98.1 %id) | ||
FN149945 | breast carcinoma | .f | 1725 to 1803 | 1 to 80 | 80/80 (100 %) | 6 diff (92.5 %id) | |||
FN165293 | breast carcinoma | .f | 1543 to 1629 | 1 to 87 | 87/87 (100 %) | 2 diff (97.8 %id) | |||
FN166109 | breast carcinoma | .a | 5566 to 5661 | 1 to 95 | 95/95 (100 %) | 1 diff (99.0 %id) | |||
FN173009 | breast carcinoma | .a | 4011 to 4109 | 98 to 1 | Submitted on the opposite strand | 98/98 (100 %) | 1 diff (99.0 %id) | ||
D80397 | brain | .a | 7360 to 7744 | 385 to 1 | 385/387 (99 %) | 0 diff (100 %id) | |||
D80398 | brain | .a | 6244 to 6485 | 1 to 242 | 242/242 (100 %) | 2 diff (99.2 %id) | |||
D60177 | brain | .a | 7564 to 7744 | 189 to 1 | 424/456 (92 %) | 25 diff (94.6 %id) | |||
D80618 | brain | .a | 6244 to 6486 | 1 to 244 | 244/244 (100 %) | 1 diff (99.6 %id) | |||
D80856 | brain | .a | 6244 to 6517 | 1 to 275 | 275/275 (100 %) | 2 diff (99.3 %id) | |||
D81176 | brain | .a | 6244 to 6473 | 1 to 231 | 231/235 (98 %) | 2 diff (99.2 %id) | |||
D60880 | .a | 6976 to 7325 | 1 to 351 | 351/351 (100 %) | 2 diff (99.5 %id) | ||||
D81356 | brain | .a | 6976 to 7378 | 1 to 403 | 403/403 (100 %) | 3 diff (99.3 %id) | |||
DB463362 | hippocampus | .a | 6152 to 6578 | 1 to 427 | 427/432 (98 %) | 5 diff (98.9 %id) | |||
DB529223 | hippocampus | .a | 7522 to 7742 | 1 to 224 | Submitted on the opposite strand | 224/224 (100 %) | 4 diff (98.3 %id) | ||
DB484384 | hypothalamus | .a | 6006 to 6440 | 1 to 435 | 435/435 (100 %) | 2 diff (99.6 %id) | |||
DB553325 | hypothalamus | .a | 7301 to 7742 | 1 to 442 | Submitted on the opposite strand | 442/442 (100 %) | 2 diff (99.6 %id) | ||
BY796708 | eye | .j | 16 to 645 | 1 to 630 | 630/630 (100 %) | 0 diff (100 %id) | |||
BY797831 | eye | .a | 505 to 992 | 1 to 488 | 488/488 (100 %) | 0 diff (100 %id) | |||
M85829 | .e | 450 to 689 | 243 to 1 | 243/244 (99 %) | 4 diff (98.4 %id) | ||||
CD676601 | eye, Trabecular meshwork | .a | 4851 to 5108 | 1 to 258 | 258/319 (80 %) | 0 diff (100 %id) | |||
R14359 | whole brain | .a | 5341 to 5704 | 1 to 378 | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 378/435 (86 %) | 26 diff (94.1 %id) | ||
R40732 | whole brain | .a | 6070 to 6355 | 314 to 22 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 293/349 (83 %) | 14 diff (96.0 %id) | |
R15233 | whole brain | .a | 5340 to 5723 | 1 to 396 | 396/407 (97 %) | 24 diff (94.2 %id) | |||
R67543 | placenta | .a | 7109 to 7492 | 1 to 389 | fully sequenced, | 389/389 (100 %) | 3 diff (99.3 %id) | ||
R67544 | placenta | .a | 7462 to 7738 | 282 to 1 | fully sequenced, | 282/282 (100 %) | 4 diff (98.6 %id) | ||
R69868 | placenta | .a | 7381 to 7709 | 341 to 1 | fully sequenced, | 341/341 (100 %) | 9 diff (97.4 %id) | ||
R69913 | placenta | .a | 7004 to 7411 | 1 to 412 | fully sequenced, | 412/412 (100 %) | 4 diff (99.1 %id) | ||
AF088016 | .c | 5408 to 6001 | 1 to 594 | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 594/594 (100 %) | 1 diff (99.9 %id) | ||
N47254 | multiple sclerosis lesions | .c | 5461 to 5641 | 1 to 182 | 182/187 (97 %) | 2 diff (99.0 %id) | |||
N47255 | multiple sclerosis lesions | .c | 5514 to 5991 | 482 to 1 | 482/483 (99 %) | 9 diff (98.2 %id) | |||
N51643 | multiple sclerosis lesions | .a | 7344 to 7742 | 410 to 2 | 409/427 (95 %) | 0 diff (100 %id) | |||
W01858 | lung | .r-u | 746 to 1017 | 1 to 277 | 277/278 (99 %) | 7 diff (97.5 %id) | |||
W52091 | Pancreas, pancreatic islet | .a | 5315 to 5883 | 1 to 566 | 566/569 (99 %) | 15 diff (97.4 %id) | |||
W59969 | Pancreas, pancreatic islet | .a | 5963 to 6375 | 418 to 1 | 418/418 (100 %) | 8 diff (98.1 %id) | |||
AA026617 | heart | .a | 5923 to 6355 | 459 to 29 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 431/432 (99 %) | 3 diff (99.4 %id) | |
AA026729 | heart | .a | 5746 to 6220 | 1 to 474 | 474/474 (100 %) | 4 diff (99.2 %id) | |||
W86970 | liver and spleen | .a | 3253 to 3530 | 287 to 1 | Submitted on the opposite strand | 287/291 (98 %) | 15 diff (94.9 %id) | ||
W86971 | liver and spleen | .q-u | 618 to 991 | 1 to 375 | Submitted on the opposite strand | 375/375 (100 %) | 4 diff (99.0 %id) | ||
AA777858 | liver and spleen | .a | 5911 to 6352 | 442 to 1 | 442/442 (100 %) | 1 diff (99.8 %id) | |||
AA056926 | uterus | .a | 5224 to 5467 | 1 to 250 | 250/255 (98 %) | 9 diff (96.5 %id) | |||
AA057071 | uterus | .a | 5974 to 6345 | 373 to 1 | 373/373 (100 %) | 4 diff (99.0 %id) | |||
AA099904 | uterus | .a | 5209 to 5818 | 1 to 605 | fully sequenced, | 605/605 (100 %) | 10 diff (98.4 %id) | ||
AA102106 | uterus | .a | 5788 to 6371 | 578 to 1 | fully sequenced, | 578/578 (100 %) | 12 diff (98.0 %id) | ||
AA668248 | .a | 6004 to 6375 | 368 to 1 | 368/368 (100 %) | 10 diff (97.3 %id) | ||||
AA668280 | .a | 6144 to 6374 | 230 to 1 | 230/230 (100 %) | 1 diff (99.6 %id) | ||||
AA553519 | Schwannoma tumor | .s-u | 1 to 411 | 411 to 1 | tiling clone, | 411/411 (100 %) | 0 diff (100 %id) | ||
AA621788 | .a | 7301 to 7743 | 445 to 3 | 443/445 (99 %) | 0 diff (100 %id) | ||||
AA600297 | .a | 6092 to 6365 | 281 to 5 | 277/281 (98 %) | 0 diff (100 %id) | ||||
AA931594 | carcinoid, lung | .c | 4647 to 5027 | 1 to 381 | Submitted on the opposite strand | 381/381 (100 %) | 0 diff (100 %id) | ||
AA987216 | carcinoid, lung | .a | 5953 to 6367 | 415 to 1 | 415/415 (100 %) | 1 diff (99.8 %id) | |||
AI017861 | Kidney | .a | 5933 to 6354 | 424 to 3 | 422/424 (99 %) | 0 diff (100 %id) | |||
AI052089 | liver and spleen | .h | 480 to 916 | 436 to 1 | tiling clone, | 436/436 (100 %) | 3 diff (99.4 %id) | ||
AI039461 | .a | 7329 to 7744 | 425 to 9 | 417/425 (98 %) | 0 diff (100 %id) | ||||
AI052457 | liver and spleen | .q-u | 618 to 938 | 1 to 321 | Submitted on the opposite strand | 321/321 (100 %) | 1 diff (99.7 %id) | ||
AI141556 | heart | .a | 7158 to 7742 | 597 to 13 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 585/585 (100 %) | 0 diff (100 %id) | |
AI093460 | uterus | .a | 5984 to 6370 | 387 to 1 | 387/387 (100 %) | 1 diff (99.8 %id) | |||
AI127033 | heart | .a | 5933 to 6373 | 443 to 3 | 441/443 (99 %) | 0 diff (100 %id) | |||
AI130725 | heart | .p | 210 to 746 | 537 to 1 | exact | tiling clone, | 537/537 (100 %) | 0 diff (100 %id) | |
AI220065 | pooled | .a | 7395 to 7744 | 354 to 5 | 350/354 (98 %) | 0 diff (100 %id) | |||
AI286145 | pooled | .i-u | 2086 to 2454 | 1 to 369 | Submitted on the opposite strand | 369/369 (100 %) | 23 diff (93.8 %id) | ||
AI246495 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 6126 to 6446 | 321 to 1 | 321/321 (100 %) | 0 diff (100 %id) | |||
AI198416 | anaplastic oligodendroglioma, brain | .a | 5890 to 6357 | 468 to 1 | 468/468 (100 %) | 1 diff (99.8 %id) | |||
AI276206 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 7300 to 7738 | 439 to 1 | 439/439 (100 %) | 0 diff (100 %id) | |||
AI278486 | placenta | .a | 7291 to 7743 | 456 to 4 | 453/456 (99 %) | 0 diff (100 %id) | |||
AI335180 | 2 pooled tumors (clear cell type), Kidney | .a | 6400 to 6836 | 439 to 3 | 437/439 (99 %) | 0 diff (100 %id) | |||
AI338604 | .c | 5707 to 6148 | 458 to 17 | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 442/442 (100 %) | 3 diff (99.4 %id) | ||
AI493171 | uterus | .a | 5901 to 6374 | 474 to 1 | 474/474 (100 %) | 1 diff (99.8 %id) | |||
AI382726 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .f | 1933 to 2210 | 280 to 1 | 280/280 (100 %) | 4 diff (98.6 %id) | |||
AI377837 | pooled | .a | 4884 to 5108 | 256 to 32 | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 225/225 (100 %) | 8 diff (96.5 %id) | |
AI422365 | brain, glioblastoma (pooled) | .a | 7302 to 7746 | 446 to 2 | 445/446 (99 %) | 0 diff (100 %id) | |||
AI424867 | pooled | .c | 4600 to 5056 | 457 to 1 | tiling clone, | 457/457 (100 %) | 0 diff (100 %id) | ||
AI580392 | Kidney | .f | 1818 to 2209 | 392 to 1 | 392/392 (100 %) | 1 diff (99.8 %id) | |||
AI918266 | anaplastic oligodendroglioma, brain | .a | 7529 to 7744 | 216 to 1 | 216/216 (100 %) | 2 diff (99.1 %id) | |||
AI621236 | pooled germ cell tumors | .a | 7435 to 7744 | 319 to 10 | 310/319 (97 %) | 0 diff (100 %id) | |||
AI655720 | pooled germ cell tumors | .a | 7435 to 7736 | 320 to 19 | AAA | 302/310 (97 %) | 0 diff (100 %id) | ||
AI637778 | pooled germ cell tumors | .c | 5705 to 6148 | 464 to 21 | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 444/444 (100 %) | 1 diff (99.8 %id) | |
AI636113 | Kidney | .a | 5828 to 6354 | 526 to 1 | 526/526 (100 %) | 2 diff (99.7 %id) | |||
AI631935 | Kidney | .a | 5849 to 6374 | 525 to 1 | 525/525 (100 %) | 2 diff (99.7 %id) | |||
AI650422 | pooled germ cell tumors | .a | 5988 to 6446 | 460 to 1 | 460/460 (100 %) | 2 diff (99.6 %id) | |||
AI807328 | carcinoid, lung | .a | 6025 to 6371 | 347 to 1 | 347/347 (100 %) | 4 diff (98.9 %id) | |||
AI912777 | carcinoid, lung | .a | 7163 to 7746 | 584 to 2 | 583/584 (99 %) | 0 diff (100 %id) | |||
AI807209 | pooled | .e | 1505 to 2187 | 684 to 1 | tiling clone, | 684/684 (100 %) | 10 diff (98.6 %id) | ||
AI807740 | pooled | .c | 4558 to 4980 | 423 to 1 | 423/423 (100 %) | 3 diff (99.3 %id) | |||
AI769071 | pooled | .a | 7294 to 7743 | 457 to 8 | 450/457 (98 %) | 0 diff (100 %id) | |||
AI817202 | pooled | .a | 7214 to 7698 | 521 to 38 | 484/521 (92 %) | 0 diff (100 %id) | |||
AI738738 | colon, colon tumor, RER+ | .a | 5880 to 6355 | 476 to 1 | 476/476 (100 %) | 3 diff (99.4 %id) | |||
AI962678 | pooled germ cell tumors | .a | 7331 to 7742 | 423 to 12 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 412/412 (100 %) | 0 diff (100 %id) | |
AI985308 | Kidney | .a | 7340 to 7743 | 404 to 1 | 404/404 (100 %) | 0 diff (100 %id) | |||
AW003653 | brain, four pooled pituitary adenomas | .a | 7163 to 7746 | 587 to 4 | tiling clone, | 584/587 (99 %) | 0 diff (100 %id) | ||
AW149694 | brain, medulloblastoma | .a | 5902 to 6376 | 477 to 1 | 477/477 (100 %) | 3 diff (99.4 %id) | |||
AW151967 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 7601 to 7742 | 169 to 28 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 142/142 (100 %) | 0 diff (100 %id) | |
AW190746 | adenocarcinoma, Pancreas | .c | 4557 to 4854 | 298 to 1 | 298/298 (100 %) | 1 diff (99.7 %id) | |||
AW589353 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 5937 to 6358 | 422 to 1 | 422/422 (100 %) | 2 diff (99.6 %id) | |||
AW274910 | pooled germ cell tumors | .a | 7368 to 7743 | 381 to 6 | 376/381 (98 %) | 0 diff (100 %id) | |||
AW241675 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 7329 to 7742 | 414 to 1 | 414/414 (100 %) | 0 diff (100 %id) | |||
AW136937 | .a | 6338 to 6462 | 125 to 1 | 125/125 (100 %) | 4 diff (96.8 %id) | ||||
AW204457 | .a | 6145 to 6446 | 314 to 13 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 302/305 (99 %) | 2 diff (99.4 %id) | ||
AW517940 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 5975 to 6359 | 385 to 1 | 385/385 (100 %) | 1 diff (99.8 %id) | |||
BE049355 | adenocarcinoma, Pancreas | .a | 7413 to 7743 | 336 to 6 | 331/336 (98 %) | 0 diff (100 %id) | |||
AW339107 | adenocarcinoma, Pancreas | .a | 7271 to 7743 | 474 to 2 | 473/474 (99 %) | 0 diff (100 %id) | |||
AW615204 | Kidney | .a | 7294 to 7744 | 463 to 13 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 451/451 (100 %) | 0 diff (100 %id) | |
BE044270 | pooled | .a | 5880 to 6338 | 459 to 1 | 459/459 (100 %) | 3 diff (99.4 %id) | |||
BE048457 | Kidney | .a | 6077 to 6355 | 279 to 1 | 279/279 (100 %) | 0 diff (100 %id) | |||
BE222391 | carcinoid, lung | .a | 7541 to 7743 | 209 to 7 | 203/209 (97 %) | 0 diff (100 %id) | |||
BE219421 | carcinoid, lung | .a | 3699 to 4036 | 337 to 1 | 337/411 (81 %) | 15 diff (96.4 %id) | |||
BE552301 | pooled germ cell tumors | .a | 5924 to 6446 | 523 to 1 | 523/523 (100 %) | 1 diff (99.9 %id) | |||
CB048164 | Prostate | .a | 7423 to 7742 | 344 to 24 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 321/321 (100 %) | 1 diff (99.7 %id) | |
CB048165 | Prostate | .a | 7300 to 7453 | 1 to 154 | fully sequenced, | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 154/154 (100 %) | 0 diff (100 %id) | |
BE671509 | carcinoid, lung | .a | 7250 to 7736 | 504 to 18 | AAA | 487/493 (98 %) | 0 diff (100 %id) | ||
BE646018 | Prostate | .a | 7333 to 7742 | 410 to 1 | 410/410 (100 %) | 0 diff (100 %id) | |||
BF111565 | pooled | .a | 7341 to 7743 | 406 to 4 | 403/406 (99 %) | 0 diff (100 %id) | |||
BF109225 | pooled | .a | 7185 to 7743 | 565 to 6 | 560/565 (99 %) | 0 diff (100 %id) | |||
BF437003 | Prostate | .a | 6124 to 6305 | 1 to 182 | Submitted on the opposite strand | 182/182 (100 %) | 0 diff (100 %id) | ||
BE562771 | endometrium, adenocarcinoma cell line, uterus | .a | 5570 to 6302 | 1 to 731 | 731/731 (100 %) | 10 diff (98.7 %id) | |||
BF222939 | pooled germ cell tumors | .a | 7285 to 7744 | 461 to 2 | 460/461 (99 %) | 0 diff (100 %id) | |||
BF337236 | brain, glioblastoma with EGFR amplification | .r-u | 457 to 1252 | 1 to 822 | tiling clone, | 822/1082 (75 %) | 69 diff (93.7 %id) | ||
BF340916 | brain, glioblastoma with EGFR amplification | .a | 5169 to 5814 | 27 to 668 | 642/668 (96 %) | 6 diff (99.2 %id) | |||
BF576579 | muscle (skeletal) | .a | 6768 to 7398 | 1 to 628 | 628/803 (78 %) | 12 diff (98.6 %id) | |||
BF670286 | muscle (skeletal) | .a | 6460 to 7128 | 1 to 664 | 664/693 (95 %) | 13 diff (98.2 %id) | |||
BG403259 | bladder, transitional cell papilloma, cell line | .a | 6049 to 6537 | 1 to 489 | 489/490 (99 %) | 12 diff (97.6 %id) | |||
BG393077 | embryonal carcinoma, cell line, testis | .a | 2401 to 2839 | 30 to 478 | 427/478 (89 %) | 30 diff (93.8 %id) | |||
BG426447 | Kidney | .a | 6629 to 7434 | 1 to 807 | 807/811 (99 %) | 16 diff (98.1 %id) | |||
BI831278 | brain, medulla | .k | 25 to 587 | 1 to 564 | tiling clone, | 564/690 (81 %) | 7 diff (99.0 %id) | ||
BM479650 | embryonal carcinoma, cell line, testis | .a | 5275 to 6270 | 1 to 998 | 998/1032 (96 %) | 28 diff (97.3 %id) | |||
CK905364 | insulinoma, Pancreas | .d | 818 to 1397 | 1 to 580 | 580/580 (100 %) | 9 diff (98.5 %id) | |||
BQ020028 | Chondrosarcoma, Left Pubic Bone | .a | 7093 to 7744 | 668 to 17 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 652/652 (100 %) | 4 diff (99.4 %id) | |
BM998333 | lung, Metastatic Chondrosarcoma | .a | 7158 to 7742 | 604 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 586/586 (100 %) | 1 diff (99.9 %id) | |
CB216524 | normal endometrium, mid-secretory phase,cycle day 23, uterus | .a | 6671 to 7305 | 1 to 635 | 635/635 (100 %) | 0 diff (100 %id) | |||
BU153099 | embryonal carcinoma, cell line, testis | .a | 2302 to 2913 | 1 to 625 | 625/890 (70 %) | 22 diff (97.6 %id) | |||
BQ889468 | dorsal root ganglia | .a | 1771 to 2623 | 9 to 869 | 861/910 (94 %) | 19 diff (98.0 %id) | |||
BQ938948 | sciatic nerve | .a | 4948 to 5813 | 1 to 870 | tiling clone, | 870/871 (99 %) | 12 diff (98.7 %id) | ||
BC062367 | Spleen | .f | 816 to 2209 | 840 to 2233 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) | 2233/2233 (100 %) | 0 diff (100 %id) |
BQ877145 | epidermoid carcinoma, cell line, lung | .a | 4046 to 4823 | 1 to 789 | 789/1001 (78 %) | 30 diff (97.1 %id) | |||
BU554129 | ovary, teratocarcinoma, cell line | .g | 1 to 848 | 1 to 853 | Y12I Y13M T15H K17S P18L ... | tiling clone, | 853/892 (95 %) | 9 diff (99.0 %id) | |
BU556664 | ovary, teratocarcinoma, cell line | .a | 4645 to 5467 | 1 to 833 | 833/973 (85 %) | 17 diff (98.3 %id) | |||
CX870322 | embryonic stem | .a | 6949 to 7744 | 814 to 19 | tiling clone, AAA | Submitted on the opposite strand | 796/796 (100 %) | 0 diff (100 %id) | |
CX870332 | embryonic stem | .a | 4277 to 5142 | 1 to 866 | tiling clone, | 866/866 (100 %) | 0 diff (100 %id) | ||
CX783802 | human embryonic stem cells | .r-u | 687 to 1006 | 1 to 320 | 320/320 (100 %) | 2 diff (99.4 %id) | |||
CX753748 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .e | 1081 to 1731 | 91 to 739 | tiling clone, | Submitted on the opposite strand | 619/741 (83 %) | 70 diff (90.6 %id) | |
CD643150 | Embryonic Stem cells | .l | 371 to 1152 | 1 to 773 | tiling clone, | 773/816 (94 %) | 21 diff (97.5 %id) | ||
CF146379 | CNCAP(3)T-225 cell line, Prostate | .a | 6366 to 7038 | 8 to 679 | tiling clone, | 672/679 (98 %) | 2 diff (99.8 %id) | ||
TI_57176956 | .k | 25 to 689 | 68 to 740 | V134S N135K G136W C137M S138F ... | tiling clone, | 673/757 (88 %) | 32 diff (95.8 %id) | ||
BP281753 | bone marrow | .l | 1 to 581 | 1 to 583 | 583/583 (100 %) | 4 diff (99.4 %id) | |||
BP282317 | bone marrow | .l | 1 to 589 | 1 to 589 | tiling clone, | 589/589 (100 %) | 0 diff (100 %id) | ||
CB143636 | Liver | .r-u | 669 to 1007 | 1 to 339 | 339/339 (100 %) | 2 diff (99.5 %id) | |||
BP289722 | lung | .d | 637 to 1217 | 1 to 582 | tiling clone, | 582/582 (100 %) | 1 diff (99.9 %id) | ||
DA646855 | mammary gland | .q-u | 1 to 380 | 2 to 381 | capped | 380/380 (100 %) | 0 diff (100 %id) | ||
DB361627 | mammary gland | .q-u | 1616 to 2180 | 568 to 1 | 568/571 (99 %) | 10 diff (98.3 %id) | |||
DA649493 | .a | 3725 to 4256 | 2 to 533 | capped | 532/532 (100 %) | 0 diff (100 %id) | |||
CD579546 | brain | .a | 2112 to 2670 | 1 to 559 | 559/715 (78 %) | 6 diff (99.2 %id) | |||
NM_004742.2 | .c | 816 to 6154 | 840 to 6178 | exact | RefSeq, | 6178/6178 (100 %) | 0 diff (100 %id) | ||
NM_015520.1 | .b | 816 to 7211 | 840 to 7235 | exact | RefSeq, | 7235/7235 (100 %) | 0 diff (100 %id) | ||
NM_001033057.1 | .a | 816 to 7038 | 840 to 7062 | exact | RefSeq, | 7062/7062 (100 %) | 0 diff (100 %id) | ||
DA714603 | .a | 4066 to 4476 | 2 to 413 | capped | 412/412 (100 %) | 1 diff (99.8 %id) | |||
DA789152 | brain | .a | 2183 to 2760 | 2 to 581 | capped | 580/580 (100 %) | 2 diff (99.7 %id) | ||
CV574828 | cornea, eye | .i-u | 2031 to 2625 | 1 to 595 | 595/595 (100 %) | 0 diff (100 %id) | |||
CD721895 | eye, lacrimal gland | .e | 116 to 740 | 1 to 623 | tiling clone, | 623/623 (100 %) | 1 diff (99.9 %id) | ||
CK430330 | eye, lacrimal gland | .a | 6004 to 6593 | 1 to 591 | tiling clone, | 591/591 (100 %) | 2 diff (99.7 %id) | ||
AU134100 | ovary, tumor tissue | .a | 4539 to 5309 | 2 to 774 | capped | 773/773 (100 %) | 4 diff (99.5 %id) | ||
AU155206 | ovary, tumor tissue | .a | 5851 to 6374 | 523 to 1 | 523/525 (99 %) | 5 diff (99.1 %id) | |||
BM789196 | stomach | .a | 5363 to 6055 | 1 to 693 | tiling clone, | 693/693 (100 %) | 0 diff (100 %id) | ||
BM763095 | myeloma | .a | 3613 to 4281 | 1 to 669 | 669/669 (100 %) | 0 diff (100 %id) | |||
BM847101 | myeloma | .a | 3613 to 4135 | 1 to 522 | 522/522 (100 %) | 2 diff (99.7 %id) | |||
BM848545 | myeloma | .a | 3613 to 4008 | 1 to 396 | 396/396 (100 %) | 0 diff (100 %id) | |||
BM848605 | myeloma | .a | 3613 to 4085 | 1 to 471 | 471/471 (100 %) | 2 diff (99.6 %id) | |||
BM849220 | myeloma | .a | 3613 to 4270 | 1 to 658 | 658/658 (100 %) | 0 diff (100 %id) | |||
BM850899 | stomach | .a | 5636 to 6083 | 1 to 448 | 448/448 (100 %) | 2 diff (99.6 %id) | |||
DA897844 | skeletal muscle | .r-u | 514 to 1072 | 2 to 560 | tiling clone, capped | 559/559 (100 %) | 1 diff (99.9 %id) | ||
DA945283 | Spleen | .s-u | 24 to 580 | 2 to 558 | tiling clone, capped | 557/558 (99 %) | 1 diff (99.9 %id) | ||
DA953750 | Spleen | .a | 5352 to 5904 | 2 to 555 | capped | 554/554 (100 %) | 2 diff (99.7 %id) | ||
DA962238 | stomach | .r-u | 1 to 854 | 2 to 854 | tiling clone, capped | 853/853 (100 %) | 10 diff (98.9 %id) | ||
DB334309 | stomach | .r-u | 1323 to 1828 | 506 to 1 | P28X | tiling clone, | 506/506 (100 %) | 4 diff (99.3 %id) | |
DR003592 | hippocampus | .a | 392 to 806 | 9 to 423 | 415/423 (98 %) | 6 diff (98.6 %id) | |||
DB025577 | testis | .k | 24 to 570 | 2 to 548 | tiling clone, capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
DB033065 | testis | .o | 1 to 572 | 2 to 573 | exact | tiling clone, capped | 572/572 (100 %) | 0 diff (100 %id) | |
DB053457 | testis | .k | 1 to 567 | 2 to 568 | tiling clone, capped | 567/567 (100 %) | 1 diff (99.9 %id) | ||
DB057823 | testis | .a | 4458 to 4981 | 2 to 528 | capped | 527/527 (100 %) | 3 diff (99.5 %id) | ||
DB075350 | testis | .m | 1 to 555 | 2 to 559 | Q39R T164Q E165T W167E T168W ... | tiling clone, capped | 558/558 (100 %) | 6 diff (99.0 %id) | |
DB081147 | testis | .a | 1850 to 2407 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
BP361317 | thalamus | .d | 16 to 596 | 1 to 581 | 581/583 (99 %) | 2 diff (99.7 %id) | |||
DB118296 | thymus | .a | 4013 to 4577 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
TI_149286260 | .a | 6995 to 7742 | 822 to 79 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 744/800 (93 %) | 27 diff (96.7 %id) | ||
TI_149293644 | .a | 5466 to 6378 | 971 to 69 | 903/1083 (83 %) | 0 diff (100 %id) | ||||
TI_149293839 | .a | 7168 to 7742 | 665 to 87 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 579/938 (61 %) | 65 diff (93.1 %id) | ||
TI_154020244 | .a | 5663 to 6378 | 777 to 61 | 717/777 (92 %) | 0 diff (100 %id) | ||||
TI_154178810 | .a | 6366 to 7225 | 76 to 938 | 863/863 (100 %) | 10 diff (98.9 %id) | ||||
U80754 | .b | 950 to 2980 | 1 to 2031 | 2031/2031 (100 %) | 1 diff (100.0 %id) | ||||
U96115 | .a | 956 to 1614 | 1 to 659 | 659/673 (97 %) | 1 diff (99.9 %id) | ||||
BM971888 | lung | .a | 7154 to 7742 | 607 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 589/589 (100 %) | 5 diff (99.2 %id) | |
BU682672 | lung | .a | 5727 to 6355 | 644 to 16 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 629/629 (100 %) | 2 diff (99.7 %id) | |
CB241134 | Human Lung Epithelial cells, lung | .a | 7015 to 7742 | 747 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 729/729 (100 %) | 3 diff (99.6 %id) | |
BM717629 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4050 to 4478 | 1 to 429 | fully sequenced, | 429/429 (100 %) | 0 diff (100 %id) | ||
BU739191 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4448 to 5071 | 624 to 1 | tiling clone, fully sequenced, | 624/624 (100 %) | 3 diff (99.6 %id) | ||
BM716032 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4088 to 4492 | 1 to 405 | fully sequenced, | 405/405 (100 %) | 0 diff (100 %id) | ||
BU739777 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4462 to 5071 | 610 to 1 | fully sequenced, | 610/610 (100 %) | 2 diff (99.7 %id) | ||
BM930454 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 7042 to 7303 | 1 to 262 | 262/266 (98 %) | 1 diff (99.7 %id) | |||
BQ187224 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 6752 to 7199 | 1 to 448 | fully sequenced, | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 448/448 (100 %) | 0 diff (100 %id) | |
CK300559 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 7169 to 7736 | 582 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 564/564 (100 %) | 1 diff (99.9 %id) | |
BQ187397 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 5800 to 6148 | 1 to 349 | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 349/349 (100 %) | 0 diff (100 %id) | |
CA436947 | Bone, Subchondral Bone | .a | 7326 to 7744 | 437 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 419/419 (100 %) | 0 diff (100 %id) | |
CA438356 | lung, Metastatic Chondrosarcoma | .a | 5840 to 6355 | 531 to 16 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 516/516 (100 %) | 1 diff (99.9 %id) | |
BQ576182 | Chondrosarcoma Grade II, Left Pelvis | .a | 7015 to 7744 | 747 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 729/729 (100 %) | 1 diff (99.9 %id) | |
TI_151734192 | .a | 6901 to 7736 | 916 to 89 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 828/929 (89 %) | 16 diff (98.3 %id) | ||
TI_151734382 | .c | 5800 to 6148 | 435 to 87 | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 349/934 (37 %) | 0 diff (100 %id) | ||
DB256356 | uterus | .a | 5370 to 5948 | 2 to 581 | capped | 580/580 (100 %) | 2 diff (99.7 %id) | ||
DB265275 | uterus | .a | 5372 to 5934 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DB278926 | uterus | .a | 1225 to 1765 | 2 to 542 | capped | 541/542 (99 %) | 1 diff (99.9 %id) | ||
DB280347 | uterus | .a | 78 to 623 | 2 to 546 | capped | 545/545 (100 %) | 1 diff (99.9 %id) | ||
W26805 | eye, retina | .t-u | 1 to 234 | 27 to 260 | exact | tiling clone, | 234/281 (83 %) | 2 diff (99.3 %id) | |
AF401655. matches multiple genes | .a | 4539 to 5309 | 2 to 774 | This clone was ignored, also hits gene gleenobo | 773/773 (100 %) | 4 diff (99.5 %id) | |||
AF401655. matches multiple genes | .a | 5851 to 6374 | 523 to 1 | This clone was ignored, also hits gene gleenobo | 523/525 (99 %) | 5 diff (99.1 %id) | |||
AK024170. matches multiple genes | mammary gland | .a | 5363 to 6055 | 1 to 693 | tiling clone, available from FLJ, | This clone was ignored, also hits gene donarbo, royura | 693/693 (100 %) | 0 diff (100 %id) | |
AK024170. matches multiple genes | mammary gland | .a | 3613 to 4281 | 1 to 669 | available from FLJ, | This clone was ignored, also hits gene donarbo, royura | 669/669 (100 %) | 0 diff (100 %id) | |
AK024170. matches multiple genes | mammary gland | .a | 3613 to 4135 | 1 to 522 | available from FLJ, | This clone was ignored, also hits gene donarbo, royura | 522/522 (100 %) | 2 diff (99.7 %id) | |
AK310365. matches multiple genes | testis | .a | 3613 to 4008 | 1 to 396 | This clone was ignored, also hits gene royura, skeynobo | 396/396 (100 %) | 0 diff (100 %id) | ||
AK310365. matches multiple genes | testis | .a | 3613 to 4085 | 1 to 471 | This clone was ignored, also hits gene royura, skeynobo | 471/471 (100 %) | 2 diff (99.6 %id) | ||
AK310365. matches multiple genes | testis | .a | 3613 to 4270 | 1 to 658 | This clone was ignored, also hits gene royura, skeynobo | 658/658 (100 %) | 0 diff (100 %id) | ||
BI430544. matches multiple genes | endometrium | .a | 5636 to 6083 | 1 to 448 | AAA | Suspected internal deletion, this clone was ignored, also hits gene jorsweyby | 448/448 (100 %) | 2 diff (99.6 %id) | |
BI430544. matches multiple genes | endometrium | .r-u | 514 to 1072 | 2 to 560 | tiling clone, AAA | Suspected internal deletion, this clone was ignored, also hits gene jorsweyby | 559/559 (100 %) | 1 diff (99.9 %id) | |
BI430553. matches multiple genes | endometrium | .s-u | 24 to 580 | 2 to 558 | tiling clone, AAA | Suspected internal deletion, this clone was ignored, also hits gene jorsweyby | 557/558 (99 %) | 1 diff (99.9 %id) | |
BI430553. matches multiple genes | endometrium | .a | 5352 to 5904 | 2 to 555 | AAA | Suspected internal deletion, this clone was ignored, also hits gene jorsweyby | 554/554 (100 %) | 2 diff (99.7 %id) | |
DA105353 | cerebellum | .r-u | 1 to 854 | 2 to 854 | tiling clone, capped | 853/853 (100 %) | 10 diff (98.9 %id) | ||
T69604 | Liver | .r-u | 1323 to 1828 | 506 to 1 | tiling clone, | 506/506 (100 %) | 4 diff (99.3 %id) | ||
T69677 | Liver | .a | 392 to 806 | 9 to 423 | 415/423 (98 %) | 6 diff (98.6 %id) | |||
BG399078 | Kidney | .k | 24 to 570 | 2 to 548 | tiling clone, | 547/547 (100 %) | 1 diff (99.9 %id) | ||
BU159638 | eye, retinoblastoma | .o | 1 to 572 | 2 to 573 | tiling clone, | 572/572 (100 %) | 0 diff (100 %id) | ||
BQ706291 | Spleen | .k | 1 to 567 | 2 to 568 | tiling clone, available from MGC, | 567/567 (100 %) | 1 diff (99.9 %id) | ||
BM762845 | lymph node, stomach | .a | 4458 to 4981 | 2 to 528 | 527/527 (100 %) | 3 diff (99.5 %id) | |||
BM844027 | lymph node, stomach | .m | 1 to 555 | 2 to 559 | tiling clone, | 558/558 (100 %) | 6 diff (99.0 %id) | ||
BM843919 | lymph node, stomach | .a | 1850 to 2407 | 2 to 559 | 558/558 (100 %) | 0 diff (100 %id) | |||
BQ446527. matches multiple genes | Knee, Osteoarthritic Cartilage | .d | 16 to 596 | 1 to 581 | This clone was ignored, also hits gene jarbarbo, royura | 581/583 (99 %) | 2 diff (99.7 %id) | ||
BQ446527. matches multiple genes | Knee, Osteoarthritic Cartilage | .a | 4013 to 4577 | 2 to 566 | This clone was ignored, also hits gene jarbarbo, royura | 565/565 (100 %) | 0 diff (100 %id) | ||
BQ446527. matches multiple genes | Knee, Osteoarthritic Cartilage | .a | 6995 to 7742 | 822 to 79 | This clone was ignored, also hits gene jarbarbo, royura | 744/800 (93 %) | 27 diff (96.7 %id) | ||
TI_149293644 | .a | 5466 to 6378 | 971 to 69 | 903/1083 (83 %) | 0 diff (100 %id) | ||||
TI_149293839 | .a | 7168 to 7742 | 665 to 87 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 579/938 (61 %) | 65 diff (93.1 %id) | ||
TI_154020244 | .a | 5663 to 6378 | 777 to 61 | 717/777 (92 %) | 0 diff (100 %id) | ||||
TI_154178810 | .a | 6366 to 7225 | 76 to 938 | 863/863 (100 %) | 10 diff (98.9 %id) | ||||
U80754 | .b | 950 to 2980 | 1 to 2031 | 2031/2031 (100 %) | 1 diff (100.0 %id) | ||||
U96115 | .a | 956 to 1614 | 1 to 659 | 659/673 (97 %) | 1 diff (99.9 %id) | ||||
BM971888 | lung | .a | 7154 to 7742 | 607 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 589/589 (100 %) | 5 diff (99.2 %id) | |
BU682672 | lung | .a | 5727 to 6355 | 644 to 16 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 629/629 (100 %) | 2 diff (99.7 %id) | |
CB241134 | Human Lung Epithelial cells, lung | .a | 7015 to 7742 | 747 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 729/729 (100 %) | 3 diff (99.6 %id) | |
CB241134 | Human Lung Epithelial cells, lung | .a | 7015 to 7742 | 747 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 729/729 (100 %) | 3 diff (99.6 %id) | |
BM717629 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4050 to 4478 | 1 to 429 | fully sequenced, | 429/429 (100 %) | 0 diff (100 %id) | ||
BM717629 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4050 to 4478 | 1 to 429 | fully sequenced, | 429/429 (100 %) | 0 diff (100 %id) | ||
BU739191 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4448 to 5071 | 624 to 1 | tiling clone, fully sequenced, | 624/624 (100 %) | 3 diff (99.6 %id) | ||
BU739191 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4448 to 5071 | 624 to 1 | tiling clone, fully sequenced, | 624/624 (100 %) | 3 diff (99.6 %id) | ||
BM716032 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4088 to 4492 | 1 to 405 | fully sequenced, | 405/405 (100 %) | 0 diff (100 %id) | ||
BM716032 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4088 to 4492 | 1 to 405 | fully sequenced, | 405/405 (100 %) | 0 diff (100 %id) | ||
BU739777 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4462 to 5071 | 610 to 1 | fully sequenced, | 610/610 (100 %) | 2 diff (99.7 %id) | ||
BU739777 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 4462 to 5071 | 610 to 1 | fully sequenced, | 610/610 (100 %) | 2 diff (99.7 %id) | ||
BM930454 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 7042 to 7303 | 1 to 262 | 262/266 (98 %) | 1 diff (99.7 %id) | |||
BM930454 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 7042 to 7303 | 1 to 262 | 262/266 (98 %) | 1 diff (99.7 %id) | |||
BQ187224 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 6752 to 7199 | 1 to 448 | fully sequenced, | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 448/448 (100 %) | 0 diff (100 %id) | |
BQ187224 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 6752 to 7199 | 1 to 448 | fully sequenced, | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 448/448 (100 %) | 0 diff (100 %id) | |
CK300559 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 7169 to 7736 | 582 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 564/564 (100 %) | 1 diff (99.9 %id) | |
CK300559 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 7169 to 7736 | 582 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 564/564 (100 %) | 1 diff (99.9 %id) | |
BQ187397 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 5800 to 6148 | 1 to 349 | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 349/349 (100 %) | 0 diff (100 %id) | |
BQ187397 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c | 5800 to 6148 | 1 to 349 | tiling clone, AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 349/349 (100 %) | 0 diff (100 %id) | |
CA436947 | Bone, Subchondral Bone | .a | 7326 to 7744 | 437 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 419/419 (100 %) | 0 diff (100 %id) | |
CA436947 | Bone, Subchondral Bone | .a | 7326 to 7744 | 437 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 419/419 (100 %) | 0 diff (100 %id) | |
CA438356 | lung, Metastatic Chondrosarcoma | .a | 5840 to 6355 | 531 to 16 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 516/516 (100 %) | 1 diff (99.9 %id) | |
CA438356 | lung, Metastatic Chondrosarcoma | .a | 5840 to 6355 | 531 to 16 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 516/516 (100 %) | 1 diff (99.9 %id) | |
BQ576182 | Chondrosarcoma Grade II, Left Pelvis | .a | 7015 to 7744 | 747 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 729/729 (100 %) | 1 diff (99.9 %id) | |
BQ576182 | Chondrosarcoma Grade II, Left Pelvis | .a | 7015 to 7744 | 747 to 19 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 729/729 (100 %) | 1 diff (99.9 %id) | |
TI_151734192 | .a | 6901 to 7736 | 916 to 89 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 828/929 (89 %) | 16 diff (98.3 %id) | ||
TI_151734382 | .c | 5800 to 6148 | 435 to 87 | AAA | Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) | 349/934 (37 %) | 0 diff (100 %id) | ||
DB256356 | uterus | .a | 5370 to 5948 | 2 to 581 | capped | 580/580 (100 %) | 2 diff (99.7 %id) | ||
DB265275 | uterus | .a | 5372 to 5934 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DB278926 | uterus | .a | 1225 to 1765 | 2 to 542 | capped | 541/542 (99 %) | 1 diff (99.9 %id) | ||
DB280347 | uterus | .a | 78 to 623 | 2 to 546 | capped | 545/545 (100 %) | 1 diff (99.9 %id) | ||
W26805 | eye, retina | .t-u | 1 to 234 | 27 to 260 | exact | tiling clone, | 234/281 (83 %) | 2 diff (99.3 %id) | |
W26805 | eye, retina | .t-u | 1 to 234 | 27 to 260 | exact | tiling clone, | 234/281 (83 %) | 2 diff (99.3 %id) |